CVN417
Product Specifications
Target
Others, AChR
Related Pathways
Others, Neuroscience
Bioactivity
CVN417 is an orally active antagonist of nAChR containing the α6 subunit, modulating phasic dopaminergic neurotransmission in an impulse-dependent fashion. It inhibits Ca (2+) efflux through nAChR subunits, displaying IC50 values of 0.086 μM (α6), 2.56 μM (α3), and 0.657 μM (α4) . CVN417 has shown efficacy in reducing resting tremor in rodent models, suggesting a potential to ameliorate movement disorders in conditions like Parkinson's disease [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7022063-01 0.02 mg
Recombinant Peromyscus boylii NADH-ubiquinone oxidoreductase chain 3 (MT-ND3)
Sign In for Pricing
View Details MBS7022063-02 0.1 mg
Recombinant Peromyscus boylii NADH-ubiquinone oxidoreductase chain 3 (MT-ND3)
Sign In for Pricing
View Details MBS7022063-03 5x 0.1 mg
Recombinant Peromyscus boylii NADH-ubiquinone oxidoreductase chain 3 (MT-ND3)
Sign In for Pricing
View Details